Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Congenital Complete Heart Block
- Sponsor
- Nantes University Hospital
- Enrollment
- 2600
- Locations
- 2
- Primary Endpoint
- Identification of genetic variations responsible of Atrioventricular Conduction Defects
- Last Updated
- 4 years ago
Overview
Brief Summary
Identification of genes involved in congenital atrioventricular block and progressive Cardiac Conduction Disease.
Detailed Description
Atrioventricular blocks are a heterogenous group of diseases involving children with congenital atrioventricular block (CAB) and more frequently elderly patients affected by progressive Cardiac Conduction Disease (PCCD). The aim of the study is to uncover the genetic model, likely more complex than previously appreciated, and characterize the gene expression remodelling leading to high degree of conduction defect. The recent technological developments in genomics coupled to the availability of large and highly characterized biobanks of patients have now set the stage: 1. To identify rare genetic variants/new genes contributing to CAB and PCCD by exome sequencing on familial form suspected to impact strongly the phenotype 2. To identify common genetic variants modulating the risk of developing (severe) PCCD by GWAS 3. To estimate the prevalence and relevance of genes uncovered by TASK#1, #2 in large patient sets (PCCD and CAB) by NGS.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Identification of genetic variations responsible of Atrioventricular Conduction Defects
Time Frame: inclusion